
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Sydney Jennings is the editor of Patient Care Online. She joined MJH Life Sciences in March 2018 after graduating from the University of Connecticut with a BA in Journalism. She can be reached at SJennings@mjhlifesciences.com.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

New real-world data from England suggests that the Oxford-AstraZeneca and Pfizer-BioNTech COVID-19 vaccines are highly effective in reducing infections among older patients.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Johnson & Johnson's COVID-19 vaccine is now the third vaccine to receive emergency use authorization in the US.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new modeling study estimates that 64% of US COVID-19 hospitalizations were attributable to at least 1 of 4 pre-existing cardiometabolic conditions.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Results of a new study show that the Pfizer-BioNTech COVID-19 vaccine is 92% effective at preventing severe COVID-19 after 2 doses in over half a million study participants.

Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

The FDA announced today that Johnson & Johnson's single-dose COVID-19 vaccine was found to be safe and effective against the novel disease.

Get a first look at key 8 studies to be presented at the upcoming AAAAI 2021 virtual meeting starting this Friday, February 26, 2021.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

US COVID-19 mortalities have surpassed 500 000. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

In a new survey of patients with severe asthma, COVID-19-related anxiety was found to be a potential risk factor for clinical worsening of disease and decline in quality of life.

US confirmed cases of COVID-19 have surpassed 28 million; global cases have reached 111 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Irregular sleeping patterns can increase risk of depression and lower daily mood over the long term, according to a new study of first-year medical students.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

SAMPLE: Approximately what percentage of the total US population had an STI at a given point in 2018? Plus 6 more questions on STI trends based on the latest CDC data.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new review of >60 000 patients with diabetes found CGM use during the early weeks of the COVID-19 pandemic improved their time in range.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

New research suggests obesity is responsible for 30%-53% of new type 2 diabetes cases in the US annually.

Global confirmed cases of COVID-19 have surpassed 109 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Global confirmed cases of COVID-19 have surpassed 108 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Double-masking found to reduce SARS-CoV-2 spread, FDA decision on antibody cocktail for treatment of COVID-19, and 8 more news briefs summarized for primary care.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

In the first study of its kind, pre-existing eosinophilia was protective from COVID-19-related hospital admission and mortality in patients with asthma.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

The FDA issued an EUA to Eli Lilly and Company for bamlanivimab and etesevimab administered together for the treatment of mild-to-moderate COVID-19.